| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 2197 |
|---|
| 5 | 5 | | To prevent 340B covered entities from using savings derived for sex |
|---|
| 6 | 6 | | reassignment surgeries, hormonal therapies, and for other purposes. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | MARCH18, 2025 |
|---|
| 9 | 9 | | Mr. J |
|---|
| 10 | 10 | | OHNSONof South Dakota (for himself, Mr. AUSTINSCOTTof Georgia, |
|---|
| 11 | 11 | | Mr. C |
|---|
| 12 | 12 | | RENSHAW, Mr. RULLI, Mr. EZELL, Mrs. BICE, Mr. MOOREof Ala- |
|---|
| 13 | 13 | | bama, and Mr. R |
|---|
| 14 | 14 | | OSE) introduced the following bill; which was referred |
|---|
| 15 | 15 | | to the Committee on Energy and Commerce |
|---|
| 16 | 16 | | A BILL |
|---|
| 17 | 17 | | To prevent 340B covered entities from using savings derived |
|---|
| 18 | 18 | | for sex reassignment surgeries, hormonal therapies, and |
|---|
| 19 | 19 | | for other purposes. |
|---|
| 20 | 20 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 21 | 21 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 22 | 22 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 23 | 23 | | This Act may be cited as the ‘‘No 340B Savings for 4 |
|---|
| 24 | 24 | | Transgender Care Act’’. 5 |
|---|
| 25 | 25 | | VerDate Sep 11 2014 01:21 Mar 29, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2197.IH H2197 |
|---|
| 26 | 26 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 27 | 27 | | •HR 2197 IH |
|---|
| 28 | 28 | | SEC. 2. PROHIBITION ON USE OF 340B SAVINGS FOR SERV-1 |
|---|
| 29 | 29 | | ICES DESCRIBED FOR TRANSGENDER INDI-2 |
|---|
| 30 | 30 | | VIDUALS. 3 |
|---|
| 31 | 31 | | (a) P |
|---|
| 32 | 32 | | ROHIBITION ONUSE OF340B SAVINGS FOR 4 |
|---|
| 33 | 33 | | S |
|---|
| 34 | 34 | | ERVICESDESCRIBED.—Section 340B(a)(4) of the Public 5 |
|---|
| 35 | 35 | | Health Service Act (42 U.S.C. 256b(a)(5)) is amended by 6 |
|---|
| 36 | 36 | | adding at the end the following: 7 |
|---|
| 37 | 37 | | ‘‘(E) P |
|---|
| 38 | 38 | | ROHIBITION ON USE OF 340B SAV -8 |
|---|
| 39 | 39 | | INGS FOR SERVICES DESCRIBED .—A covered 9 |
|---|
| 40 | 40 | | entity participating in the program under this 10 |
|---|
| 41 | 41 | | section may not use any funds derived from the 11 |
|---|
| 42 | 42 | | difference between the 340B ceiling price and 12 |
|---|
| 43 | 43 | | the actual acquisition cost of covered outpatient 13 |
|---|
| 44 | 44 | | drugs to pay for services described. 14 |
|---|
| 45 | 45 | | ‘‘(i) D |
|---|
| 46 | 46 | | EFINITIONS.—For purposes of 15 |
|---|
| 47 | 47 | | this subsection— 16 |
|---|
| 48 | 48 | | ‘‘(I) C |
|---|
| 49 | 49 | | OVERED ENTITY .—The 17 |
|---|
| 50 | 50 | | term ‘covered entities’ has the mean-18 |
|---|
| 51 | 51 | | ing given such term in section 19 |
|---|
| 52 | 52 | | 340B(a)(4). 20 |
|---|
| 53 | 53 | | ‘‘(II) S |
|---|
| 54 | 54 | | ERVICES DESCRIBED .— 21 |
|---|
| 55 | 55 | | The term ‘services described’ means— 22 |
|---|
| 56 | 56 | | ‘‘(aa) sex reassignment sur-23 |
|---|
| 57 | 57 | | geries furnished for the purpose 24 |
|---|
| 58 | 58 | | of the gender alteration of a 25 |
|---|
| 59 | 59 | | transgender individual; and 26 |
|---|
| 60 | 60 | | VerDate Sep 11 2014 01:21 Mar 29, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2197.IH H2197 |
|---|
| 61 | 61 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 62 | 62 | | •HR 2197 IH |
|---|
| 63 | 63 | | ‘‘(bb) hormone treatments 1 |
|---|
| 64 | 64 | | furnished for the purpose of the 2 |
|---|
| 65 | 65 | | gender alteration of a 3 |
|---|
| 66 | 66 | | transgender individual.’’. 4 |
|---|
| 67 | 67 | | Æ |
|---|
| 68 | 68 | | VerDate Sep 11 2014 01:21 Mar 29, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H2197.IH H2197 |
|---|
| 69 | 69 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|